Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-01-08 @ 2:33 PM
Study NCT ID:
NCT03333005
Status:
COMPLETED
Last Update Posted:
2024-05-17
First Post:
2017-10-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia
Sponsor:
Basilea Pharmaceutica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-26
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-23
First Submit QC Date:
None
Study First Post Date:
2017-11-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-16
Last Update Post Date:
2024-05-17
Last Update Post Date Type:
ACTUAL